Cincinnati, OHNCT06343792Now EnrollingIRB Ready

Graft-versus-Host Disease Clinical Trial in Cincinnati, OH

Access cutting-edge graft-versus-host disease treatment through this clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.

Sponsored by ReAlta Life Sciences, Inc.

Quick Self-Assessment

See if you qualify for this Cincinnati location

Preparing your pre-screening questions...

Expert Care in Cincinnati

Access graft-versus-host disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related graft-versus-host disease treatment provided free

Apply for This Cincinnati Location

Check if you qualify for this graft-versus-host disease clinical trial in Cincinnati, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cincinnati

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cincinnati site if eligible
  4. 4Begin participation

About This Graft-versus-Host Disease Study in Cincinnati

This study is a Open Label Prospective Dose-Ranging Escalation and Expansion Trial to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Dosing, and Efficacy of RLS-0071 for the secondary treatment of acute Graft-versus-Host Disease (aGvHD) in hospitalized patients who are steroid-refractory.

Sponsor: ReAlta Life Sciences, Inc.

Who Can Participate

Inclusion Criteria

Male or female adults or adolescents (\>12 years old).
Hospitalized with steroid-refractory aGvHD (grade II-IV) after allo-HSCT
Anticipated hospital length-of-stay of at least 1 week from the time of RLS-0071 initiation.
No plans to add additional GvHD treatment medications or to add, dose-adjust, or discontinue GvHD prophylactic medications during the 7-days of RLS-0071 treatment.
Neutrophil recovery following the stem-cell transplantation, defined as blood neutrophil count \>500/mL for at least 3 consecutive measurements and not supported by growth factor supplementation
Weight ≥40 kg and ≤ 140 kg at screening.

Exclusion Criteria

Has received more than 1 allo-HSCT
Current, previous, or planned use of any systemic treatment in addition to or other than corticosteroids or ruxolitinib for aGvHD
Previous failure of ruxolitinib treatment
Uncontrolled GI infection
Endoscopic and biopsy testing (if performed) that definitively rules out lower GI

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cincinnati?

Yes, this clinical trial (NCT06343792) has an active research site in Cincinnati, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Graft-versus-Host Disease Treatment Options in Cincinnati, OH

If you're searching for graft-versus-host disease treatment options in Cincinnati, OH, this clinical trial (NCT06343792) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cincinnati research site is actively enrolling participants for this clinical trial. You'll receive care from experienced graft-versus-host disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all graft-versus-host disease clinical trials near you to find additional studies recruiting in your area.

More Atrial Fibrillation Trials in Cincinnati, OH

See all atrial fibrillation clinical trials recruiting in Cincinnati — not just this study.

Browse Atrial Fibrillation Trials in Cincinnati

Ready to Join in Cincinnati?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cincinnati, OH